Evidence that NADPH-dependent methemoglobin reductase and administered riboflavin protect tissues from oxidative injury (1993)

Peer-Reviewed Study · Hultquist DE; Xu F; Quandt KS; Shlafer M; Mack CP; Till GO; Seekamp A; Betz AL; Ennis SR · January 1993

Hultquist DE et al., 1993-01: Biochemistry paper (University of Michigan, USA) describing the NADPH-dependent enzyme that reduces methylene blue, and reporting pyrroloquinoline quinone (PQQ) as a high-affinity substrate of that same reductase. An enzymatic relationship between PQQ and the MB-reducing system, not a combined dosing study.

Pyrroloquinoline quinone serves as a high-affinity substrate of the reductase, suggesting that this naturally-occurring compound may be a physiological substrate.

Hultquist DE et al., 1993-01: Biochemistry paper (University of Michigan, USA) describing the NADPH-dependent enzyme that reduces methylene blue, and reporting pyrroloquinoline quinone (PQQ) as a high-affinity substrate of that same reductase. An enzymatic relationship between PQQ and the MB-reducing system, not a combined dosing study. In vitro / animal tissue biochemistry, no N for the PQQ observation. No MB+PQQ co-administration study exists in PubMed – SOURCE NOT FOUND for that pairing (see E_notes.md). Study type: lab.